(1)
Neres, I. L. do N.; Mello, R. O.; Bernardes, JúliaS.; Barbosa, J. de S. P. RISK OF CARDIOVASCULAR DISEASE ASSOCIATED WITH THE HALOPERIDOL USE IN PATIENTS WITH SCHIZOPHRENIA. REASE 2026, 12 (8), 1-27. https://doi.org/10.51891/rease.v12i8.28165.